Retatrutide decreased HbA1c by 2.02% in a phase II clinical trial, while dulaglutide 1.5 mg decreased HbA1c by 1.14% and a placebo decreased it by 0.01% [109]
Sobo provides peptide-related guidance in the context of the patients full health picture
With FDA approval of Wegovy pill, new era of oral GLP-1 weight loss drugs begins
Cold and flu-like symptoms: Headaches, nausea, vomiting, blurred vision, and fatigue
These three pathways collectively evaluate the antioxidant potential of polyphenols in protecting human health against oxidative damage (157)
Learn more here: #Epigenetics #Ketosis #BiologicalAging #PrecisionMedicine #MetabolicHealth | Josephine Barbarino To view or add a comment, sign in D-allulose is a substance that may help fight obesity by working through a pathway involving a hormone called GLP-1